Vedashwa QMS · Pharma

GMP quality, linked batch by batch

Deviations, OOS results, calibration and change control each touch batch release, and inspectors check that link. Vedashwa QMS keeps them connected, with signatures and an audit trail behind every decision.

Book a demo

Vedashwa QMS: an out-of-specification result traced to its root (pharma workspace)

batch impact recorded on every deviation
211.192batch impact recorded on every deviation
OOS rules from FDA guidance
Phase I/IIOOS rules from FDA guidance
product file for pharma
CTD M3product file for pharma

Engineered to support

21 CFR 21121 CFR Part 11EU GMP Ch. 1, 4 & 6EU GMP Annex 11ICH Q9ICH Q10ALCOA+

We build to these standards and document how the system supports them. Determining which regime applies, and certifying it, is work for qualified counsel.

Where GMP quality teams lose time and take risk

1 of 6

Deviations without batch impact

Other affected batches go unrecorded.

With Vedashwa QMSEvery deviation records its batch impact (211.192) and closes with one signed QA decision.Full traceabilityLower compliance risk

OOS results under scrutiny

Retests without an approved plan draw inspector attention.

With Vedashwa QMSAssignable cause, an approved retest plan and retests that cannot be deleted, per FDA guidance.Data integrityAudit-ready

Release decisions checked by hand

Open issues are chased across logs before release.

With Vedashwa QMSRelease stays blocked until NCs, deviations and OOS close and final inspection passes.Lower compliance riskLess effort

An instrument fails calibration

Nobody knows which results relied on it.

With Vedashwa QMSAn impact assessment covers every record that used it.Full traceabilityPatient safety

Changes go live before people are trained

SOPs take effect before training catches up.

With Vedashwa QMSRevisions assign retraining; change control closes after training.Always currentAudit-ready

Risk management on paper

Inspectors expect lifecycle risk management.

With Vedashwa QMSICH Q9 risk plans and signed acceptance; management review in ICH Q10 terms.Management oversightLower compliance risk